These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30390798)

  • 21. A rapid and affordable screening platform for membrane protein trafficking.
    Snyder JC; Pack TF; Rochelle LK; Chakraborty SK; Zhang M; Eaton AW; Bai Y; Ernst LA; Barak LS; Waggoner AS; Caron MG
    BMC Biol; 2015 Dec; 13():107. PubMed ID: 26678094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biophysical methods in drug discovery from small molecule to pharmaceutical.
    Holdgate G; Geschwindner S; Breeze A; Davies G; Colclough N; Temesi D; Ward L
    Methods Mol Biol; 2013; 1008():327-55. PubMed ID: 23729258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next generation ligand binding assays-review of emerging technologies' capabilities to enhance throughput and multiplexing.
    Mora J; Given Chunyk A; Dysinger M; Purushothama S; Ricks C; Osterlund K; Theobald V
    AAPS J; 2014 Nov; 16(6):1175-84. PubMed ID: 25193269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge-Based Approaches to Off-Target Screening.
    McMasters DR
    Methods Enzymol; 2018; 610():311-323. PubMed ID: 30390804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-content screening: imaging, analysis, and applications.
    Mattheakis L
    J Biomol Screen; 2013 Aug; 18(7):845-7. PubMed ID: 23881694
    [No Abstract]   [Full Text] [Related]  

  • 26. Protein structure-based drug design: from docking to molecular dynamics.
    Śledź P; Caflisch A
    Curr Opin Struct Biol; 2018 Feb; 48():93-102. PubMed ID: 29149726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand screening using fluorescence thermal shift analysis (FTS).
    Luan CH; Light SH; Dunne SF; Anderson WF
    Methods Mol Biol; 2014; 1140():263-89. PubMed ID: 24590724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [NMR in the fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
    [No Abstract]   [Full Text] [Related]  

  • 29. The beautiful cell: high-content screening in drug discovery.
    Bickle M
    Anal Bioanal Chem; 2010 Sep; 398(1):219-26. PubMed ID: 20577725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
    Clémençon B; Lüscher BP; Hediger MA
    J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aptamer beacons for the direct detection of proteins.
    Hamaguchi N; Ellington A; Stanton M
    Anal Biochem; 2001 Jul; 294(2):126-31. PubMed ID: 11444807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Radial Capillary Action of Ligand Assay (DRaCALA).
    Seminara AB; Turdiev A; Turdiev H; Lee VT
    Curr Protoc Mol Biol; 2019 Apr; 126(1):e84. PubMed ID: 30508276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMR in drug discovery: A practical guide to identification and validation of ligands interacting with biological macromolecules.
    Gossert AD; Jahnke W
    Prog Nucl Magn Reson Spectrosc; 2016 Nov; 97():82-125. PubMed ID: 27888841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Guide to Run Affinity Screens Using Differential Scanning Fluorimetry and Surface Plasmon Resonance Assays.
    Bergsdorf C; Wright SK
    Methods Enzymol; 2018; 610():135-165. PubMed ID: 30390797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biophysics: for HTS hit validation, chemical lead optimization, and beyond.
    Genick CC; Wright SK
    Expert Opin Drug Discov; 2017 Sep; 12(9):897-907. PubMed ID: 28658992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integrated bioanalytical platform for supporting high-throughput serum protein binding screening.
    Zhang J; Shou WZ; Vath M; Kieltyka K; Maloney J; Elvebak L; Stewart J; Herbst J; Weller HN
    Rapid Commun Mass Spectrom; 2010 Dec; 24(24):3593-601. PubMed ID: 21080511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advance in phage display technology for bioanalysis.
    Tan Y; Tian T; Liu W; Zhu Z; J Yang C
    Biotechnol J; 2016 Jun; 11(6):732-45. PubMed ID: 27061133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hot topic: In vitro imaging. Editorial.
    Tang F; Xu JJ
    Comb Chem High Throughput Screen; 2009 Nov; 12(9):825-6. PubMed ID: 19938326
    [No Abstract]   [Full Text] [Related]  

  • 40. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
    Bruice TW; Lima WF
    Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.